These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19787152)

  • 41. A decision-tree approach to cost comparison of newborn screening strategies for cystic fibrosis.
    Wells J; Rosenberg M; Hoffman G; Anstead M; Farrell PM
    Pediatrics; 2012 Feb; 129(2):e339-47. PubMed ID: 22291119
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neonatal infection does not affect the immunoreactive trypsinogen screening test for cystic fibrosis.
    Wilson DC; Leslie H; Edgar JD; Halliday HL; Dodge JA
    J Pediatr Gastroenterol Nutr; 1994 Jul; 19(1):97-9. PubMed ID: 7965486
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Utility of a very high IRT/No mutation referral category in cystic fibrosis newborn screening.
    Kay DM; Langfelder-Schwind E; DeCelie-Germana J; Sharp JK; Maloney B; Tavakoli NP; Saavedra-Matiz CA; Krein LM; Caggana M; Kier C;
    Pediatr Pulmonol; 2015 Aug; 50(8):771-80. PubMed ID: 26098992
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnosing cystic fibrosis in newborn screening in Poland - 15 years of experience.
    Sands D; Zybert K; Mierzejewska E; Ołtarzewski M
    Dev Period Med; 2015; 19(1):16-24. PubMed ID: 26003066
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Five-year performance analysis of a cystic fibrosis newborn screening program in northeastern Brazil.
    Godoy C; Paixão DC; Boa-Sorte NCA; Amorim T; da Silva Filho LVRF; Souza EL
    J Pediatr (Rio J); 2023; 99(1):23-30. PubMed ID: 35679883
    [TBL] [Abstract][Full Text] [Related]  

  • 46. False-positive results in neonatal screening for cystic fibrosis based on a three-stage protocol (IRT/DNA/IRT): Should we adjust IRT cut-off to ethnic origin?
    Cheillan D; Vercherat M; Chevalier-Porst F; Charcosset M; Rolland MO; Dorche C
    J Inherit Metab Dis; 2005; 28(6):813-8. PubMed ID: 16435172
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing.
    Rock MJ; Hoffman G; Laessig RH; Kopish GJ; Litsheim TJ; Farrell PM
    J Pediatr; 2005 Sep; 147(3 Suppl):S73-7. PubMed ID: 16202788
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of two different protocols of neonatal screening for cystic fibrosis.
    Narzi L; Lucarelli M; Lelli A; Grandoni F; Lo Cicero S; Ferraro A; Matarazzo P; Delaroche I; Quattrucci S; Strom R; Antonelli M
    Clin Genet; 2002 Sep; 62(3):245-9. PubMed ID: 12220442
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Neonatal cystic fibrosis screening program in the state of Paraná: evaluation 30 months after implementation].
    Santos GP; Domingos MT; Wittig EO; Riedi CA; Rosário NA
    J Pediatr (Rio J); 2005; 81(3):240-4. PubMed ID: 15951909
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm.
    Parad RB; Comeau AM
    J Pediatr; 2005 Sep; 147(3 Suppl):S78-82. PubMed ID: 16202789
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Screening for cystic fibrosis in dried blood spots of newborns.
    Audrézet MP; Costes B; Ghanem N; Fanen P; Verlingue C; Morin JF; Mercier B; Goossens M; Férec C
    Mol Cell Probes; 1993 Dec; 7(6):497-502. PubMed ID: 8145780
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development and characterization of dried blood spot materials for the measurement of immunoreactive trypsinogen.
    Li L; Zhou Y; Bell CJ; Earley MC; Hannon WH; Mei JV
    J Med Screen; 2006; 13(2):79-84. PubMed ID: 16792830
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of national coverage of neonatal cystic fibrosis screening in Brazil from 2008 to 2017.
    Sadigurschi G; Vaz Micherino B; Assunção Mendes da Cunha MB; Antão Paiva CL; da Silva E Sá GR
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):5204-5209. PubMed ID: 33491525
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neonatal screening for cystic fibrosis in Brittany, France: assessment of 10 years' experience and impact on prenatal diagnosis.
    Scotet V; de Braekeleer M; Roussey M; Rault G; Parent P; Dagorne M; Journel H; Lemoigne A; Codet JP; Catheline M; David V; Chaventré A; Duguépéroux I; Verlingue C; Quéré I; Mercier B; Audrézet MP; Férec C
    Lancet; 2000 Sep; 356(9232):789-94. PubMed ID: 11022925
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Implementation of newborn screening for cystic fibrosis in Norway. Results from the first three years.
    Lundman E; Gaup HJ; Bakkeheim E; Olafsdottir EJ; Rootwelt T; Storrøsten OT; Pettersen RD
    J Cyst Fibros; 2016 May; 15(3):318-24. PubMed ID: 26795017
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessing the improvements in the newborn screening strategy for cystic fibrosis in the Balearic Islands.
    Bauça JM; Morell-Garcia D; Vila M; Pérez G; Heine-Suñer D; Figuerola J
    Clin Biochem; 2015 Apr; 48(6):419-24. PubMed ID: 25680858
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A product of immunoreactive trypsinogen and pancreatitis-associated protein as second-tier strategy in cystic fibrosis newborn screening.
    Weidler S; Stopsack KH; Hammermann J; Sommerburg O; Mall MA; Hoffmann GF; Kohlmüller D; Okun JG; Macek M; Votava F; Krulišová V; Balaščaková M; Skalická V; Lee-Kirsch MA; Stopsack M
    J Cyst Fibros; 2016 Nov; 15(6):752-758. PubMed ID: 27461140
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunoreactive Trypsinogen (IRT) as a Biomarker for Cystic Fibrosis: challenges in newborn dried blood spot screening.
    Therrell BL; Hannon WH; Hoffman G; Ojodu J; Farrell PM
    Mol Genet Metab; 2012 May; 106(1):1-6. PubMed ID: 22425451
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nutritional benefits of neonatal screening for cystic fibrosis. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.
    Farrell PM; Kosorok MR; Laxova A; Shen G; Koscik RE; Bruns WT; Splaingard M; Mischler EH
    N Engl J Med; 1997 Oct; 337(14):963-9. PubMed ID: 9395429
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Generation and characterization of murine monoclonal antibodies against immunoreactive trypsinogen for newborn screening of cystic fibrosis.
    Morejón García G; García de la Rosa I; Feal Carballo S; Castells Martínez EM; Stable Vernier IC; Quintana Guerra JM; Hernández Pérez L; Lafita Delfino Y; Pérez Morás PL; Pupo Infante M; Figueredo Lago JE; González Reyes EC
    Anal Biochem; 2020 Feb; 591():113569. PubMed ID: 31887264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.